CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 471851754
- Phone
- 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-03 | PAKOLA STEVE Chief Medical Officer | Grant or award | +8,900 | 17,150 | ||
| 2022-01-03 | PAKOLA STEVE Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +42,500 | 42,500 | ||
| 2022-01-03 | Danos Olivier Chief Scientific Officer | Grant or award | +10,700 | 29,078 | ||
| 2022-01-03 | Danos Olivier Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +51,100 | 51,100 | ||
| 2022-01-03 | Christmas Patrick J. Chief Legal Officer | Grant or award | +7,900 | 22,940 | ||
| 2022-01-03 | Christmas Patrick J. Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +37,400 | 37,400 | ||
| 2022-01-03 | Mills Kenneth T. President and CEO | Grant or award | +35,796 | 309,844 | ||
| 2022-01-03 | Mills Kenneth T. President and CEO | Grant or award · Stock Option (Right to Buy) | +170,188 | 170,188 | ||
| 2022-01-01 | Simpson Curran Chief Oper. & Tech. Officer | Shares withheld for taxes | −1,332 | $32.70 | $44K | 16,416 |
| 2022-01-01 | PAKOLA STEVE Chief Medical Officer | Shares withheld for taxes | −1,152 | $32.70 | $38K | 9,848 |
| 2022-01-01 | Danos Olivier Chief Scientific Officer | Shares withheld for taxes | −1,221 | $32.70 | $40K | 18,378 |
| 2022-01-01 | Christmas Patrick J. Chief Legal Officer | Shares withheld for taxes | −1,332 | $32.70 | $44K | 15,040 |
| 2022-01-01 | Mills Kenneth T. President and CEO | Shares withheld for taxes | −3,636 | $32.70 | $119K | 274,048 |
| 2021-12-31 | Danos Olivier Chief Scientific Officer | Grant or award | +1 | $27.80 | $28 | 19,599 |
| 2021-12-23 | Fox Allan M. Director | Sale | −44,908 | $34.92 | $1.6M | 1,536,304 |
| 2021-12-23 | Fox Allan M. Director | Sale | −6,323 | $35.85 | $227K | 1,529,981 |
| 2021-12-22 | Fox Allan M. Director | Sale | −61,638 | $34.40 | $2.1M | 1,581,212 |
| 2021-12-02 | Mills Kenneth T. President and CEO | Gift | −3,300 | 277,684 | ||
| 2021-11-08 | Mills Kenneth T. President and CEO | Option exercise | +1,500 | $3.76 | $6K | 282,484 |
| 2021-11-08 | Mills Kenneth T. President and CEO | Sale | −1,500 | $40.00 | $60K | 280,984 |
Page 15 of 25 · 494 trades